STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 97 filers reported holding STOKE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $240,537 | -46.8% | 28,876 | -41.0% | 0.00% | -66.7% |
| Q4 2022 | $452,048 | +140.5% | 48,976 | +234.6% | 0.00% | +200.0% |
| Q3 2022 | $188,000 | -65.9% | 14,636 | -64.9% | 0.00% | -66.7% |
| Q2 2022 | $551,000 | -41.6% | 41,728 | -6.9% | 0.00% | -62.5% |
| Q1 2022 | $944,000 | +235.9% | 44,844 | +282.9% | 0.01% | +166.7% |
| Q4 2021 | $281,000 | -8.2% | 11,713 | -2.7% | 0.00% | -25.0% |
| Q3 2021 | $306,000 | -14.0% | 12,033 | +13.7% | 0.00% | 0.0% |
| Q2 2021 | $356,000 | +49.0% | 10,582 | +71.6% | 0.00% | +33.3% |
| Q1 2021 | $239,000 | – | 6,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |